1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations

2. Executive Summary
2.1. Market Size & Estimates
2.2. Market Overview

3. Market Dynamics
3.1. Market Definition
3.2. Key Drivers
3.2.1. Modern Dietary Habits Taking Toll On The Health
3.2.2. Ibs Can Be A Heritability Issue
3.2.3. Availability Of Effective Drugs In The Market
3.3. Key Restraints
3.3.1. Strict Fda Regulations
3.3.2. Unawareness And Ignorance Among People

4. Key Analytics
4.1. Key Investment Insights
4.2. Porter’S Five Force Analysis
4.2.1. Buyer Power
4.2.2. Supplier Power
4.2.3. Substitution
4.2.4. New Entrants
4.2.5. Industry Rivalry
4.3. Opportunity Matrix
4.4. Vendor Landscape
4.5. Regulatory Framework

5. Market By Prescription Type
5.1. Prescribed
5.1.1. Branded
5.1.2. Generic
5.2. Over The Counter

6. Market By Drug Type
6.1. Lubiprostone
6.2. Linaclotide
6.3. Stimulant Laxatives
6.3.1. Bisacodyl
6.3.2. Senna
6.4. Osmotic Laxatives
6.4.1. Lactulose
6.4.2. Polyethylene Glycol
6.5. Other Drug Types

7. Geographical Analysis
7.1. North America
7.1.1. United States
7.1.2. Canada
7.2. Europe
7.2.1. United Kingdom
7.2.2. Germany
7.2.3. France
7.2.4. Italy
7.2.5. Russia
7.2.6. Belgium
7.2.7. Poland
7.2.8. Rest Of Europe
7.3. Asia Pacific
7.3.1. China
7.3.2. Japan
7.3.3. India
7.3.4. South Korea
7.3.5. Indonesia
7.3.6. Thailand
7.3.7. Vietnam
7.3.8. Australia & New Zealand
7.3.9. Rest Of Asia Pacific
7.4. Rest Of World
7.4.1. Latin America
7.4.2. Middle East & Africa

8. Company Profiles
8.1. Catalent Pharmaceuticals Solutions
8.2. Abbott Laboratories
8.3. Novartis Pharma Ag
8.4. Astellas Pharmaceuticals
8.5. Ardelyx, Inc.
8.6. Synthetic Biologics, Inc.
8.7. Teva Pharmaceutical Industries Limited
8.8. Bama-Geve, Slu
8.9. Ferring Bv
8.10. Ironwood Pharmaceuticals, Inc.
8.11. Salix Pharmaceuticals Ltd.
8.12. Norgine B.V.
8.13. Prometheus Laboratories, Inc.
8.14. Albireo Pharma, Inc.
8.15. Yuhan Corp.
8.16. Astrazeneca Plc
8.17. The Menarini Group
8.18. Ono Pharmaceutical Co. Ltd.
8.19. Actavis Nordic A/S

List of Tables
Table 1: Market Snapshot – Ibs-C Drug
Table 2: Regulatory Framework
Table 3: Global Ibs-C Drug Market, By Prescription Type, Historical Years, 2016-2019 (In $ Million)
Table 4: Global Ibs-C Drug Market, By Prescription Type, Forecast Years, 2020-2028 (In $ Million)
Table 5: Global Prescribed Market, By Region, Historical Years, 2016-2019 (In $ Million)
Table 6: Global Prescribed Market, By Region, Forecast Years, 2020-2028 (In $ Million)
Table 7: Global Ibs-C Drug Market, By Prescribed, Historical Years, 2016-2019 (In $ Million)
Table 8: Global Ibs-C Drug Market, By Prescribed, Forecast Years, 2020-2028 (In $ Million)
Table 9: Product Profile (Methyl Naltrexone Bromide)
Table 10: Global Branded Market, By Region, Historical Years, 2016-2019 (In $ Million)
Table 11: Global Branded Market, By Region, Forecast Years, 2020-2028 (In $ Million)
Table 12: Global Generic Market, By Region, Historical Years, 2016-2019 (In $ Million)
Table 13: Global Generic Market, By Region, Forecast Years, 2020-2028 (In $ Million)
Table 14: Global Over The Counter Market, By Region, Historical Years, 2016-2019 (In $ Million)
Table 15: Global Over The Counter Market, By Region, Forecast Years, 2020-2028 (In $ Million)
Table 16: Global Ibs-C Drug Market, By Drug Type, Historical Years, 2016-2019 (In $ Million)
Table 17: Global Ibs-C Drug Market, By Drug Type, Forecast Years, 2020-2028 (In $ Million)
Table 18: Product Profile (Lubiprostone)
Table 19: Global Lubiprostone Market, By Region, Historical Years, 2016-2019 (In $ Million)
Table 20: Global Lubiprostone Market, By Region, Forecast Years, 2020-2028 (In $ Million)
Table 21: Product Profile (Linaclotide)
Table 22: Global Linaclotide Market, By Region, Historical Years, 2016-2019 (In $ Million)
Table 23: Global Linaclotide Market, By Region, Forecast Years, 2020-2028 (In $ Million)
Table 24: Global Stimulant Laxatives Market, By Region, Historical Years, 2016-2019 (In $ Million)
Table 25: Global Stimulant Laxatives Market, By Region, Forecast Years, 2020-2028 (In $ Million)
Table 26: Global Ibs-C Drug Market, By Stimulant Laxatives, Historical Years, 2016-2019 (In $ Million)
Table 27: Global Ibs-C Drug Market, By Stimulant Laxatives, Forecast Years, 2020-2028 (In $ Million)
Table 28: Product Profile (Bisacodyl)
Table 29: Global Bisacodylmarket, By Region, Historical Years, 2016-2019 (In $ Million)
Table 30: Global Bisacodylmarket, By Region, Forecast Years, 2020-2028 (In $ Million)
Table 31: Product Profile (Senna)
Table 32: Global Senna Market, By Region, Historical Years, 2016-2019 (In $ Million)
Table 33: Global Senna Market, By Region, Forecast Years, 2020-2028 (In $ Million)
Table 34: Global Osmotic Laxatives Market, By Region, Historical Years, 2016-2019 (In $ Million)
Table 35: Global Osmotic Laxatives Market, By Region, Forecast Years, 2020-2028 (In $ Million)
Table 36: Global Ibs-C Drug Market, By Osmotic Laxatives, Historical Years, 2016-2019 (In $ Million)
Table 37: Global Ibs-C Drug Market, By Osmotic Laxatives, Forecast Years, 2020-2028 (In $ Million)
Table 38: Product Profile (Lactulose)
Table 39: Global Lactulose Market, By Region, Historical Years, 2016-2019 (In $ Million)
Table 40: Global Lactulose Market, By Region, Forecast Years, 2020-2028 (In $ Million)
Table 41: Product Profile (Polyethylene Glycol)
Table 42: Global Polyethylene Glycol Market, By Region, Historical Years, 2016-2019 (In $ Million)
Table 43: Global Polyethylene Glycol Market, By Region, Forecast Years, 2020-2028 (In $ Million)
Table 44: Product Profile (Psyllium)
Table 45: Global Other Drug Types Market, By Region, Historical Years, 2016-2019 (In $ Million)
Table 46: Global Other Drug Types Market, By Region, Forecast Years, 2020-2028 (In $ Million)
Table 47: Global Ibs-C Drug Market, By Geography, Historical Years, 2016-2019 (In $ Million)
Table 48: Global Ibs-C Drug Market, By Geography, Forecast Years, 2020-2028 (In $ Million)
Table 49: North America Ibs-C Drug Market, By Country, Historical Years, 2016-2019 (In $ Million)
Table 50: North America Ibs-C Drug Market, By Country, Forecast Years, 2020-2028 (In $ Million)
Table 51: Europe Ibs-C Drug Market, By Country, Historical Years, 2016-2019 (In $ Million)
Table 52: Europe Ibs-C Drug Market, By Country, Forecast Years, 2020-2028 (In $ Million)
Table 53: Asia Pacific Ibs-C Drug Market, By Country, Historical Years, 2016-2019 (In $ Million)
Table 54: Asia Pacific Ibs-C Drug Market, By Country, Forecast Years, 2020-2028 (In $ Million)
Table 55: Rest Of World Ibs-C Drug Market, By Region, Historical Years, 2016-2019 (In $ Million)
Table 56: Rest Of World Ibs-C Drug Market, By Region, Forecast Years, 2020-2028 (In $ Million)
List Of Figures
Figure 1: Drugs Pulled Off From The Market
Figure 2: Key Investment Insights
Figure 3: Porter’S Five Force Analysis
Figure 4: Opportunity Matrix
Figure 5: Vendor Landscape
Figure 6: Global Ibs-C Drug Market, Growth Potential, By Prescription Type, In 2019
Figure 7: Global Ibs-C Drug Market, Prescribed, 2020-2028 (In $ Million)
Figure 8: Global Ibs-C Drug Market, Branded, 2020-2028 (In $ Million)
Figure 9: Global Ibs-C Drug Market, Generic, 2020-2028 (In $ Million)
Figure 10: Global Ibs-C Drug Market, Over The Counter, 2020-2028 (In $ Million)
Figure 11: Global Ibs-C Drug Market, Growth Potential, By Drug Type, In 2019
Figure 12: Global Ibs-C Drug Market, Lubiprostone, 2020-2028 (In $ Million)
Figure 13: Global Ibs-C Drug Market, Linaclotide, 2020-2028 (In $ Million)
Figure 14: Global Ibs-C Drug Market, Stimulant Laxatives, 2020 -2028 (In $ Million)
Figure 15: Global Ibs-C Drug Market, Bisacodyl, 2020-2028 (In $ Million)
Figure 16: Global Ibs-C Drug Market, Senna, 2020-2028 (In $ Million)
Figure 17: Global Ibs-C Drug Market, Osmotic Laxatives, 2020 -2028 (In $ Million)
Figure 18: Global Ibs-C Drug Market, Bisacodyl, 2020-2028 (In $ Million)
Figure 19: Global Ibs-C Drug Market, Polyethylene Glycol, 2020-2028 (In $ Million)
Figure 20: Global Ibs-C Drug Market, Other Drug Types, 2020 -2028 (In $ Million)
Figure 21: North America Ibs-C Drug Market, Regional Outlook, 2019 & 2028 (In %)
Figure 22: United States Ibs-C Drug Market, 2020-2028 (In $ Million)
Figure 23: Canada Ibs-C Drug Market, 2020-2028 (In $ Million)
Figure 24: Europe Ibs-C Drug Market, Regional Outlook, 2019 & 2028 (In %)
Figure 25: United Kingdom Ibs-C Drug Market, 2020-2028 (In $ Million)
Figure 26: Germany Ibs-C Drug Market, 2020-2028 (In $ Million)
Figure 27: France Ibs-C Drug Market, 2020-2028 (In $ Million)
Figure 28: Italy Ibs-C Drug Market, 2020-2028 (In $ Million)
Figure 29: Russia Ibs-C Drug Market, 2020-2028 (In $ Million)
Figure 30: Belgium Ibs-C Drug Market, 2020-2028 (In $ Million)
Figure 31: Poland Ibs-C Drug Market, 2020-2028 (In $ Million)
Figure 32: Rest Of Europe Ibs-C Drug Market, 2020-2028 (In $ Million)
Figure 33: Asia Pacific Ibs-C Drug Market, Regional Outlook, 2019 & 2028 (In %)
Figure 34: China Ibs-C Drug Market, 2020-2028 (In $ Million)
Figure 35: Chinese Medicine Tcm Treatment For Ibs
Figure 36: Japan Ibs-C Drug Market, 2020-2028 (In $ Million)
Figure 37: India Ibs-C Drug Market, 2020-2028 (In $ Million)
Figure 38: South Korea Ibs-C Drug Market, 2020-2028 (In $ Million)
Figure 39: Indonesia Ibs-C Drug Market, 2020-2028 (In $ Million)
Figure 40: Thailand Ibs-C Drug Market, 2020-2028 (In $ Million)
Figure 41: Vietnam Ibs-C Drug Market, 2020-2028 (In $ Million)
Figure 42: Australia & New Zealand Ibs-C Drug Market, 2020-2028 (In $ Million)
Figure 43: Rest Of Asia Pacific Ibs-C Drug Market, 2020-2028 (In $ Million)
Figure 44: Rest Of World Ibs-C Drug Market, Regional Outlook, 2019 & 2028 (In %)
Figure 45: Latin America Ibs-C Drug Market, 2020-2028 (In $ Million)
Figure 46: Middle East & Africa Ibs-C Drug Market, 2020-2028 (In $ Million)